FACTOR-VII COAGULANT ACTIVITY AND CHOLESTEROL CHANGES IN PREMENOPAUSAL WOMEN CONSUMING A LONG-TERM CHOLESTEROL-LOWERING DIET

被引:22
作者
BRACE, LD
GITTLERBUFFA, C
MILLER, GJ
COLE, TG
SCHMEISSER, D
PREWITT, TE
BOWEN, PE
机构
[1] UNIV ILLINOIS,DEPT MED LAB SCI,CHICAGO,IL
[2] UNIV ILLINOIS,DEPT NUTR & MED DIETET,CHICAGO,IL 60680
[3] NORTHWICK PK HOSP & CLIN RES CTR,MRC,EPIDEMIOL & MED CARE UNIT,HARROW,MIDDX,ENGLAND
[4] WASHINGTON UNIV,DEPT MED,LIPID RES CTR,ST LOUIS,MO
[5] LOYOLA UNIV,MED CTR,DEPT EPIDEMIOL & PREVENT MED,MAYWOOD,IL 60153
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 08期
关键词
WOMEN; DIET; FAT; FACTOR VII; CARDIOVASCULAR DISEASE;
D O I
10.1161/01.ATV.14.8.1284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We periodically obtained blood samples from mildly hypercholesterolemic, but otherwise healthy, premenopausal women who were recruited to participate in a study of a long-term, cholesterol-lowering diet. All meals were prepared and most meals were consumed in the study center dining facility. Tests performed on blood samples included fibrinogen, cholesterol, factor VII coagulant activity (VIIc), and other measures of factor VII. We found that when women switched from a typical American diet (37% fat, polyunsaturated fatty acid to saturated fatty acid [P/S] ratio 0.5, 300 mg cholesterol/d) to a diet lower in fat and cholesterol (American Heart Association phase 2 diet: 30% fat, P/S ratio of 1, 150 to 200 mg cholesterol/d) and maintained that diet for 20 weeks, their plasma cholesterol levels decreased by approximately 6% after 4 weeks and remained at that level until study termination. Likewise, VIIc decreased by approximately 11% while factor VII antigen, total factor VII activity, and fibrinogen concentration did not change appreciably from baseline values. Our results show that premenopausal women benefit from a diet lower in total and saturated fat by a reduction in blood cholesterol and VIIc. Extrapolation from data on men in the Northwick Park Heart Study indicates that the 11% decrease in VIIc activity would correspond to an approximately 30% decrease in risk of mortality from coronary heart disease.
引用
收藏
页码:1284 / 1289
页数:6
相关论文
共 56 条
  • [1] AMIRAL J, 1984, CLIN CHEM, V30, P1512
  • [2] [Anonymous], 1984, LANCET, V2, P600
  • [3] INTERRELATIONSHIP OF PLASMA TRIGLYCERIDE AND COAGULANT FACTOR-VII LEVELS IN NORMOTRIGLYCERIDEMIC HYPERCHOLESTEROLEMIA
    BRUCKERT, E
    DESOUSA, JC
    GIRAL, P
    SORIA, C
    CHAPMAN, MJ
    CAEN, J
    DEGENNES, JL
    [J]. ATHEROSCLEROSIS, 1989, 75 (2-3) : 129 - 134
  • [4] RELATION OF SERUM TOTAL CHOLESTEROL AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL PERCENTAGE TO THE INCIDENCE OF DEFINITE CORONARY EVENTS - 20-YEAR FOLLOW-UP OF THE DONOLO-TEL-AVIV PROSPECTIVE CORONARY-ARTERY DISEASE STUDY
    BRUNNER, D
    WEISBORT, J
    MESHULAM, N
    SCHWARTZ, S
    GROSS, J
    SALTZRENNERT, H
    ALTMAN, S
    LOEBL, K
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (15) : 1271 - 1276
  • [5] CARDIOVASCULAR MORTALITY AND NONCONTRACEPTIVE USE OF ESTROGEN IN WOMEN - RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY
    BUSH, TL
    BARRETTCONNOR, E
    COWAN, LD
    CRIQUI, MH
    WALLACE, RB
    SUCHINDRAN, CM
    TYROLER, HA
    RIFKIND, BM
    [J]. CIRCULATION, 1987, 75 (06) : 1102 - 1109
  • [6] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN
    CANNER, PL
    BERGE, KG
    WENGER, NK
    STAMLER, J
    FRIEDMAN, L
    PRINEAS, RJ
    FRIEDEWALD, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255
  • [7] DIFFERENTIAL REDUCTION OF PLASMA-CHOLESTEROL BY THE AMERICAN-HEART-ASSOCIATION PHASE-3 DIET IN MODERATELY HYPERCHOLESTEROLEMIC, PREMENOPAUSAL WOMEN WITH DIFFERENT BODY-MASS INDEXES
    COLE, TG
    BOWEN, PE
    SCHMEISSER, D
    PREWITT, TE
    AYE, P
    LANGENBERG, P
    DOLECEK, TA
    BRACE, LD
    KAMATH, S
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (02) : 385 - 394
  • [8] ESPANA F, 1983, J LAB CLIN MED, V102, P31
  • [9] FAIR DS, 1983, BLOOD, V62, P784
  • [10] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245